<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000661177"><TermName>efavirenz</TermName><TermPronunciation>(ee-FAH-vih-renz)</TermPronunciation><TermDefinition><DefinitionText>A drug used with other drugs to treat infection with the human immunodeficiency virus (HIV). It blocks HIV from making copies of itself. It is a type of non-nucleoside reverse transcriptase inhibitor and a type of antiviral agent. Also called Sustiva.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726319" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;efavirenz&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726318" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;efavirenz&quot;" language="es" id="_4"/><SpanishTermName>efavirenz</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la infección por el virus de la inmunodeficiencia humana (VIH). Impide que el VIH haga copias de sí mismo. Es un tipo de inhibidor no nucleosídico de la retrotranscriptasa y un tipo de antivírico. También se llama Sustiva.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-03-30</DateFirstPublished></GlossaryTerm>
